Discover CAR T-cell and non-Hodgkin lymphoma (NHL) expert-driven strategies to enhance patient selection in our upcoming live webinar where faculty will provide actionable insights on recognizing clinical indicators and navigating eligibility criteria to identify appropriate candidates for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Leveraging key insights stemming from recent surveys and CAR T clinical connection sessions and the introduction of a customizable Referral Ready blueprint, expert faculty will present the latest evidence and guideline recommendations to ensure your patients receive timely, potentially life-changing treatment.